<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal disease</z:e> in <z:hpo ids='HP_0002044'>Zollinger-Ellison syndrome</z:hpo> is being recognized with increasing frequency, <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> is seen only rarely </plain></SENT>
<SENT sid="1" pm="."><plain>Basal lower esophageal sphincter pressure is probably not different in <z:hpo ids='HP_0002044'>Zollinger-Ellison syndrome</z:hpo> and non-<z:hpo ids='HP_0002044'>Zollinger-Ellison syndrome</z:hpo> patients </plain></SENT>
<SENT sid="2" pm="."><plain>Circulating gastrin, therefore, cannot be the major determinant of lower esophageal sphincter pressure in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>Total gastrectomy and resection of <z:hpo ids='HP_0000001'>all</z:hpo> metaplastic esophagus, when feasible, is the treatment of choice for patients with <z:hpo ids='HP_0002044'>Zollinger-Ellison syndrome</z:hpo> and Barrett mucosa </plain></SENT>
</text></document>